[DISBIOTIC AND IMMUNOLOGICAL CHANGES OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ITS COMBINATION WITH

Insights

Chronic obstructive pulmonary disease (COPD) patients with arterial hypertension exhibit worsened dysbiosis and immune dysfunction. These changes correlate with the severity of hypertension, impacting cellular, humoral, and phagocytic immunity.

Area of Science:

  • Immunology
  • Pulmonology
  • Microbiology

Background:

  • Chronic obstructive pulmonary disease (COPD) is often comorbid with arterial hypertension.
  • The interplay between COPD, arterial hypertension, and immune system dysregulation requires further investigation.

Purpose of the Study:

  • To investigate microflora and immune parameters in patients with COPD, differentiating between isolated COPD and COPD with arterial hypertension.
  • To assess the impact of hypertension severity on dysbiotic and immune profiles in COPD patients.

Main Methods:

  • Evaluated fecal caseinolitic activity for dysbiosis.
  • Assessed immune status via leukogram, immunogram, CD3+, CD4+, CD8+, CD19+ cell levels, Ig A, Ig M, Ig G, and NST-test.
  • Compared immune and microflora indicators between COPD patients with and without hypertension, and across hypertension severity grades (I-III).

Main Results:

  • COPD patients with arterial hypertension showed more pronounced dysbiosis and inflammatory syndrome compared to those with isolated COPD.
  • Weakened cellular immunity, heightened humoral immunity, and altered phagocytic immunity were observed in COPD patients with hypertension.
  • Dysbiotic and immune alterations intensified with increasing hypertension severity from grade I to III.

Conclusions:

  • Arterial hypertension exacerbates dysbiosis and immune dysregulation in COPD patients.
  • Hypertension severity is directly associated with the degree of microfloral and immune system impairment in COPD.
  • Findings highlight the need for integrated management of COPD and arterial hypertension, considering immune and microfloral status.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.8K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K